Gastrointestinal Cancer Clinical Trials

RSS | Login | Register

Gastrointestinal Cancer Clinical trials

Clinical Trial: Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Clinical Trial: The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity

Clinical Trial: Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer (GIVTE)

Clinical Trial: Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers

Clinical Trial: Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Clinical Trial: Methylphenidate Study in Breast or Gastrointestinal Cancer Patients

Clinical Trial: Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

Clinical Trial: Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers

Clinical Trial: Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

Clinical Trial: Development of Early Detection Signs for Gastrointestinal Cancer

Clinical Trial: Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Clinical Trial: Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Clinical Trial: Methylphenidate Study in Breast or Gastrointestinal Cancer Patients

Clinical Trial: Development of Early Detection Signs for Gastrointestinal Cancer

Clinical Trial: Study of AV-951 Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers

For a complete listing of clinical trials pertaining to Gastrointestinal Cancer via ClinicalTrials.gov, click here.

Gastrointestinal Cancer News

Experimental agent slows progression of colorectal cancer

ASCO Gastrointestinal Cancers Symposium, Jan. 19-21, 2012

Quality of life after esophagectomy on par with general population for most

Genetic culprit in pancreatic cancer risk identified

Study demonstrates mortality disparity among colorectal cancer patients

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)^TM

This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.

Visit Reflections for first-hand stories on the power of the patient to impact caregivers in oncology nursing.

Cancer care is expensive.
CancerCare can help.

Connect Booklets

Web Exclusives

Psychosocial approach useful in managing cancer pain

Delicia Honen Yard February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.

Experimental agent slows progression of colorectal cancer

Delicia Honen Yard February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.

In HER2 breast cancer, lapatinib works better with trastuzumab than without

Delicia Honen Yard February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.